76 related articles for article (PubMed ID: 2201206)
1. Endothelin in experimental congestive heart failure in the anesthetized dog.
Cavero PG; Miller WL; Heublein DM; Margulies KB; Burnett JC
Am J Physiol; 1990 Aug; 259(2 Pt 2):F312-7. PubMed ID: 2201206
[TBL] [Abstract][Full Text] [Related]
2. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
[TBL] [Abstract][Full Text] [Related]
3. Increased endothelin in experimental heart failure.
Margulies KB; Hildebrand FL; Lerman A; Perrella MA; Burnett JC
Circulation; 1990 Dec; 82(6):2226-30. PubMed ID: 2242543
[TBL] [Abstract][Full Text] [Related]
4. Endothelin in thoracic inferior vena caval constriction model of heart failure.
Underwood RD; Aarhus LL; Heublein DM; Burnett JC
Am J Physiol; 1992 Sep; 263(3 Pt 2):H951-5. PubMed ID: 1415622
[TBL] [Abstract][Full Text] [Related]
5. Endothelin A receptor antagonism in experimental congestive heart failure results in augmentation of the renin-angiotensin system and sustained sodium retention.
Schirger JA; Chen HH; Jougasaki M; Lisy O; Boerrigter G; Cataliotti A; Burnett JC
Circulation; 2004 Jan; 109(2):249-54. PubMed ID: 14691038
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by calcium antagonism of circulating and renal endothelin in experimental congestive heart failure.
Wei C; Burnett JC
Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H263-8. PubMed ID: 10644607
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous atrial natriuretic factor in acute congestive heart failure.
Lee ME; Miller WL; Edwards BS; Burnett JC
J Clin Invest; 1989 Dec; 84(6):1962-6. PubMed ID: 2531762
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin in experimental congestive heart failure: cardiorenal activation.
Jougasaki M; Stevens TL; Borgeson DD; Luchner A; Redfield MM; Burnett JC
Am J Physiol; 1997 Oct; 273(4):R1392-9. PubMed ID: 9362304
[TBL] [Abstract][Full Text] [Related]
9. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure.
Wada A; Tsutamato T; Maeda Y; Kanamori T; Matsuda Y; Kinoshita M
Am J Physiol; 1996 May; 270(5 Pt 2):H1819-24. PubMed ID: 8928891
[TBL] [Abstract][Full Text] [Related]
10. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure.
Luchner A; Jougasaki M; Friedrich E; Borgeson DD; Stevens TL; Redfield MM; Riegger GA; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R974-9. PubMed ID: 10956256
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
12. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure.
Thomas PB; Liu EC; Webb ML; Mukherjee R; Hebbar L; Spinale FG
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2629-37. PubMed ID: 8997325
[TBL] [Abstract][Full Text] [Related]
13. Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure.
Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Wang X; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():254S-257S. PubMed ID: 12193098
[TBL] [Abstract][Full Text] [Related]
14. Atrial and pulmonary endothelin mRNA is increased in a canine model of chronic low cardiac output.
Wei CM; Clavell AL; Burnett JC
Am J Physiol; 1997 Aug; 273(2 Pt 2):R838-44. PubMed ID: 9277577
[TBL] [Abstract][Full Text] [Related]
15. Influence of congestive heart failure on endothelin levels and receptors in rabbits.
Löffler BM; Roux S; Kalina B; Clozel M; Clozel JP
J Mol Cell Cardiol; 1993 Apr; 25(4):407-16. PubMed ID: 8340932
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the endothelin-1 transmembrane signaling pathway: the potential role of agonist-induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure.
Calderone A; Rouleau JL; de Champlain J; Bélichard P; Stewart DJ
J Mol Cell Cardiol; 1993 Aug; 25(8):895-903. PubMed ID: 8263960
[TBL] [Abstract][Full Text] [Related]
17. Endothelin has biological actions at pathophysiological concentrations.
Lerman A; Hildebrand FL; Aarhus LL; Burnett JC
Circulation; 1991 May; 83(5):1808-14. PubMed ID: 2022031
[TBL] [Abstract][Full Text] [Related]
18. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure.
Onishi K; Ohno M; Little WC; Cheng CP
J Pharmacol Exp Ther; 1999 Mar; 288(3):1214-22. PubMed ID: 10027861
[TBL] [Abstract][Full Text] [Related]
19. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure.
Abassi Z; Francis B; Wessale J; Ovcharenko E; Winaver J; Hoffman A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():245S-248S. PubMed ID: 12193096
[TBL] [Abstract][Full Text] [Related]
20. Endothelin in congestive heart failure.
Love MP; McMurray JJ
Basic Res Cardiol; 1996; 91 Suppl 1():21-9. PubMed ID: 8896740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
